Hennekens, Charles H <br/><br/>
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitus.  [electronic resource] 

 -  Contemporary clinical trials  Sep 2010 
 - 411-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1559-2030 
<br/><br/><label>Standard No.: </label>10.1016/j.cct.2010.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus--drug therapy<br/>Drug Design<br/>Drug Industry--legislation & jurisprudence<br/>Drug-Related Side Effects and Adverse Reactions<br/>Government Regulation<br/>Guidelines as Topic<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Risk Assessment<br/>United States<br/>United States Food and Drug Administration